BeOne Medicines Ltd. (ONC): Gross Profit
$4.67B
Year ended 2025-12-31
$5.45B
Trailing 12 months to 2026-06-30
+60.6%
3-year compound annual growth
+81.4%
5-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.67B | +45.3% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $3.22B | +54.7% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $2.08B | +84.1% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $1.13B | +11.7% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $1.01B | +324.6% | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | $238.22M | -33.3% | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | $357.02M | +110.6% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $169.51M | n/a | 2021-02-25, From 2018-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $4.67B | +45.3% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $2.59B | +6.4% |
| Organon & Co. (OGN) | 2025-12-31 | $3.31B | -10.8% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $1.49B | -3.1% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $3.04B | +56.4% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $2.50B | +10.1% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $2.80B | +9.0% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $1.11B | +9.1% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $6.80B | +4.0% |
Compare ONC, ELAN, OGN, PRGO side by side · Screen every company in Pharmaceutical Preparations ↗